Publication | Open Access

Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial

UrologyOncologyElderly PatientsCancer ManagementClinical TrialsPharmacotherapyCancer TreatmentProstatic DiseaseMedicine